Your browser doesn't support javascript.
loading
Prevention of severe immune-related colitis caused by combined immune checkpoint inhibition using vedolizumab: A case report.
Jochmann, J; Fink, A; Stella, A; Feldmann, R; Kramer, L; Posch, C.
Afiliação
  • Jochmann J; Department of Dermatology, Klinik Hietzing, Vienna, Austria.
  • Fink A; Department of Dermatology, Klinik Hietzing, Vienna, Austria.
  • Stella A; Department of Dermatology, Klinik Hietzing, Vienna, Austria.
  • Feldmann R; Department of Dermatology, Klinik Hietzing, Vienna, Austria.
  • Kramer L; Department of Gastroenterology, Klinik Hietzing, Vienna, Austria.
  • Posch C; Department of Dermatology, Klinik Hietzing, Vienna, Austria.
J Eur Acad Dermatol Venereol ; 37(7): e923-e925, 2023 07.
Article em En | MEDLINE | ID: mdl-36913261
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Colite Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Colite Idioma: En Ano de publicação: 2023 Tipo de documento: Article